Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...

CMR Surgical said its Versius system has already completed more than 26,000 keyhole procedures worldwide, as it now gears up to bring the laparoscopic robot to the U.S. (CMR Surgical) CMR Surgical ...

A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR ...

CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR Surgical said Tuesday it received 510(k) clearance from the Food and Drug Administration for its next-generation robotic ...

CMR Surgical (CMR or ‘the Company’), a global surgical robotics business, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Versius Surgical ...

“We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion, including in the U.S., while continuing to penetrate deeper into existing markets,” CEO ...

Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global ...

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, priming the company to go ahead with US commercialisation ...